Replies to post #495188 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Agree. If biotech institutional investors actually had an appetite for AVXL, Missling could do a private placement to a select group of them at $20+ per share.

Then the market can see what is the lowest this stock should be trading at.

[Jsgribbs]

They could just buy the stock now for way less than that. 🤷‍♂️

[BIOChecker4]

“Why should Missling do unnecessary dilution at the current low stock price?“

Easy! High quality and highly respected biotech institutional investors would bring something Missling desperately needs: C R E D I B I L I T Y!

But of course it’s all theoretical since none of these investors would touch Anavex with a ten-foot pole.

[ExtremelyBullishZig]

There is a common misconception that the current share price is low.